Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study

Mark Gurnell, Andrew Menzies-Gow, Liam G Heaney, Jonathan Corren, Elisabeth H Bel, Jorge F Maspero, Timothy Harrison, David Jackson, David Price, Njira Lugogo, James Kreindler, Annie Burden, Alex de Giorgio-Miller, Kelly Padilla, Ubaldo J. Martin, Esther Garcia Gil

Research output: Contribution to conferenceAbstractpeer-review

1 Downloads (Pure)

Abstract

Oral corticosteroid (OCS) dependence is prevalent in severe asthma and causes
adverse effects, including adrenal insufficiency (AI).
Original languageEnglish
Publication statusAccepted/In press - 13 Mar 2021
EventATS International Conference Committee: ATS 2021 - Virtual event
Duration: 14 May 202119 May 2021
https://conference.thoracic.org/

Conference

ConferenceATS International Conference Committee
Period14/05/2119/05/21
Internet address

Fingerprint Dive into the research topics of 'Adrenal Insufficiency is Not a Barrier to OCS Elimination in the PONENTE Study'. Together they form a unique fingerprint.

Cite this